Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation

Francesca Romana Ponziani; Brigida Eleonora Annicchiarico; Massimo Siciliano; Francesca D'Aversa; Maurizio Pompili; Antonio Gasbarrini

doi:10.3748/wjg.v19.i21.3255

Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation

Francesca Romana Ponziani, Brigida Eleonora Annicchiarico, Massimo Siciliano, Francesca D'Aversa, Maurizio Pompili, Antonio Gasbarrini

Risultato della ricerca: Contributo in rivista › Articolo in rivista

3 Citazioni (Scopus)

Abstract

To investigate differences in tolerability and response to treatment in compensated cirrhotic patients affected by hepatitis C virus (HCV) infection before and after liver transplantation.

Lingua originale	English
pagine (da-a)	3255-3262
Numero di pagine	8
Rivista	World Journal of Gastroenterology
Volume	19
DOI	https://doi.org/10.3748/wjg.v19.i21.3255
Stato di pubblicazione	Pubblicato - 2013

Keywords

Antiviral Agents
Drug Administration Schedule
Drug Therapy, Combination
Female
Hepatitis C virus
Hepatitis C virus antiviral treatment
Hepatitis C, Chronic
Humans
Interferon-alpha
Kaplan-Meier Estimate
Liver Cirrhosis
Liver Transplantation
Liver cirrhosis
Liver transplantation
Male
Middle Aged
Polyethylene Glycols
Recombinant Proteins
Retrospective Studies
Ribavirin
Safety
Sustained virological response, Efficacy
Time Factors
Treatment Outcome

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.3748/wjg.v19.i21.3255

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{50dbffdc76254769b1f891a11e64bb73,

title = "Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation",

abstract = "To investigate differences in tolerability and response to treatment in compensated cirrhotic patients affected by hepatitis C virus (HCV) infection before and after liver transplantation.",

keywords = "Antiviral Agents, Drug Administration Schedule, Drug Therapy, Combination, Female, Hepatitis C virus, Hepatitis C virus antiviral treatment, Hepatitis C, Chronic, Humans, Interferon-alpha, Kaplan-Meier Estimate, Liver Cirrhosis, Liver Transplantation, Liver cirrhosis, Liver transplantation, Male, Middle Aged, Polyethylene Glycols, Recombinant Proteins, Retrospective Studies, Ribavirin, Safety, Sustained virological response, Efficacy, Time Factors, Treatment Outcome, Antiviral Agents, Drug Administration Schedule, Drug Therapy, Combination, Female, Hepatitis C virus, Hepatitis C virus antiviral treatment, Hepatitis C, Chronic, Humans, Interferon-alpha, Kaplan-Meier Estimate, Liver Cirrhosis, Liver Transplantation, Liver cirrhosis, Liver transplantation, Male, Middle Aged, Polyethylene Glycols, Recombinant Proteins, Retrospective Studies, Ribavirin, Safety, Sustained virological response, Efficacy, Time Factors, Treatment Outcome",

author = "Ponziani, {Francesca Romana} and Annicchiarico, {Brigida Eleonora} and Massimo Siciliano and Francesca D'Aversa and Maurizio Pompili and Antonio Gasbarrini",

year = "2013",

doi = "10.3748/wjg.v19.i21.3255",

language = "English",

volume = "19",

pages = "3255--3262",

journal = "World Journal of Gastroenterology",

issn = "1007-9327",

publisher = "WJG Press:PO Box 2345, 100023 Beijing China:EMAIL: wjg@wjgnet.com, INTERNET: http://www.wjgnet.com, Fax: 011 86 10 85381893",

}

TY - JOUR

T1 - Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation

AU - Ponziani, Francesca Romana

AU - Annicchiarico, Brigida Eleonora

AU - Siciliano, Massimo

AU - D'Aversa, Francesca

AU - Pompili, Maurizio

AU - Gasbarrini, Antonio

PY - 2013

Y1 - 2013

N2 - To investigate differences in tolerability and response to treatment in compensated cirrhotic patients affected by hepatitis C virus (HCV) infection before and after liver transplantation.

AB - To investigate differences in tolerability and response to treatment in compensated cirrhotic patients affected by hepatitis C virus (HCV) infection before and after liver transplantation.

KW - Antiviral Agents

KW - Drug Administration Schedule

KW - Drug Therapy, Combination

KW - Female

KW - Hepatitis C virus

KW - Hepatitis C virus antiviral treatment

KW - Hepatitis C, Chronic

KW - Humans

KW - Interferon-alpha

KW - Kaplan-Meier Estimate

KW - Liver Cirrhosis

KW - Liver Transplantation

KW - Liver cirrhosis

KW - Liver transplantation

KW - Male

KW - Middle Aged

KW - Polyethylene Glycols

KW - Recombinant Proteins

KW - Retrospective Studies

KW - Ribavirin

KW - Safety

KW - Sustained virological response, Efficacy

KW - Time Factors

KW - Treatment Outcome

KW - Antiviral Agents

KW - Drug Administration Schedule

KW - Drug Therapy, Combination

KW - Female

KW - Hepatitis C virus

KW - Hepatitis C virus antiviral treatment

KW - Hepatitis C, Chronic

KW - Humans

KW - Interferon-alpha

KW - Kaplan-Meier Estimate

KW - Liver Cirrhosis

KW - Liver Transplantation

KW - Liver cirrhosis

KW - Liver transplantation

KW - Male

KW - Middle Aged

KW - Polyethylene Glycols

KW - Recombinant Proteins

KW - Retrospective Studies

KW - Ribavirin

KW - Safety

KW - Sustained virological response, Efficacy

KW - Time Factors

KW - Treatment Outcome

UR - http://hdl.handle.net/10807/52155

U2 - 10.3748/wjg.v19.i21.3255

DO - 10.3748/wjg.v19.i21.3255

M3 - Article

SN - 1007-9327

VL - 19

SP - 3255

EP - 3262

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

ER -

Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo